Sneddon-Wilkinson disease treated with etanercept: Report of two cases

Clinical and Experimental Dermatology

Volumn 34, Issue 3, 2009, Pages 347-351

  Berk, D R ^a   Hurt, M A ^b   Mann, C ^a   Sheinbein, D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WCP Laboratories Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; AZATHIOPRINE; CALCIPOTRIOL; CEFDINIR; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN; DAPSONE; EFALIZUMAB; ETANERCEPT; ETRETIN; HYDROQUINONE; INFLIXIMAB; KETOCONAZOLE; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NICOTINAMIDE; PIMECROLIMUS; POTASSIUM IODIDE; PREDNISONE; PSEUDOMONIC ACID; RETINOIC ACID; RETINOID; SALAZOSULFAPYRIDINE; SALICYLIC ACID; STEROID; TAZAROTENE; TETRACYCLINE;

ADULT; ARTICLE; CASE REPORT; HUMAN; HUMAN TISSUE; LOW DRUG DOSE; MALE; MONOTHERAPY; PRIORITY JOURNAL; PUSTULE; PUVA; RARE DISEASE; RASH; SKIN BIOPSY; SUBCORNEAL PUSTULAR DERMATOSIS; TREATMENT INDICATION; TREATMENT RESPONSE;

ADULT; AGED; DERMATOLOGIC AGENTS; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; SKIN DISEASES, VESICULOBULLOUS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 62449175510     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2008.02905.x     Document Type: Article

References (9)

1. Lutz ME, Daoud MS, McEvoy MT, Gibson LE. Subcorneal pustular dermatosis: a clinical study of ten patients. Cutis 1998 61 : 203 8.
2. Voigtlander C, Luftl M, Schuler G, Hertl M. Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease). Arch Dermatol 2001 137 : 1571 4.
3. Bonifati C, Trento E, Cordiali Fei P et al. Early but not lasting improvement of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease) after infliximab therapy: relationships with variations in cytokine levels in suction blister fluids. Clin Exp Dermatol 2005 30 : 662 5.
4. Raimondo N, Campos de Gonzalez L, Orden A. Sneddon-Wilkinson's syndrome: a therapeutic challenge. Poster abstract presented at the American Academy of Dermatology 65th Annual Meeting. J Am Acad Dermatol 2007 56 (Suppl. 2 AB46.
5. Iobst W, Ingraham K. Sneddon-Wilkinson disease in a patient with rheumatoid arthritis. Arthritis Rheum 2005 52 : 3771.
6. Bedi MK. Successful treatment of longstanding, recalcitrant subcorneal pustular dermatosis with etanercept. Skinmed 2007 6 : 245 7.
7. Grob JJ, Mege JL, Capo C et al. Role of tumor necrosis factor-alpha in Sneddon-Wilkinson subcorneal pustular dermatosis. A model of neutrophil priming in vivo. J Am Acad Dermatol 1991 25 : 944 7.
8. Sanchez NP, Perry HO, Muller SA, Winkelmann RK. Subcorneal pustular dermatosis and pustular psoriasis. A clinicopathologic correlation. Arch Dermatol 1983 119 : 715 21.
9. Reed J, Wilkinson J. Subcorneal pustular dermatosis. Clin Dermatol 2000 18 : 301 13.